Australia markets close in 3 hours 22 minutes

InspireMD, Inc. (NSPR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1500+0.0100 (+0.88%)
At close: 03:59PM EDT
1.1500 0.00 (0.00%)
After hours: 07:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1400
Open1.1100
Bid0.9801 x 800
Ask1.1900 x 1100
Day's range1.1100 - 1.1900
52-week range0.8100 - 3.3300
Volume9,735
Avg. volume24,456
Market cap9.586M
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)-2.3400
Earnings date30 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    InspireMD Announces Promotion of Andrea Tommasoli to Chief Operating Officer

    Mr. Tommasoli formerly served as the Company’s Senior Vice President of Global Sales & Marketing since 2020 and has significant prior commercial leadership experience at Integra LifeSciences and St. Jude MedicalTEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that it has promoted Andrea Tommasoli to Chief Operating Officer. Mr. Tommasoli formerly served

  • GlobeNewswire

    InspireMD to Report Fourth Quarter and Full-Year 2022 Financial Results on March 30, 2023, and Provide a Corporate Business Update

    -Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report fourth quarter and full-year 2022 financial results on Thursday, March 30, 2023, before the financial markets open. Management will host a conference call and webcast with the investment co

  • GlobeNewswire

    InspireMD Announces Hiring of Medical Device Commercial Veteran Shane Gleason as General Manager of North America and VP of Global Marketing

    Seasoned veteran in vascular space adds significant expertise in U.S. commercial market readiness and global strategic marketingTEL AVIV, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that it has hired medical device commercial veteran Shane Gleason as General Manager of North America and Vice President of Global Marketing. Mr. Gleason brings to InspireMD signi